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Abstract: Snake genome sequencing is in its infancy—very much behind the progress made in
sequencing the genomes of humans, model organisms and pathogens relevant to biomedical research,
and agricultural species. We provide here an overview of some of the snake genome projects in
progress, and discuss the biological findings, with special emphasis on toxinology, from the small
number of draft snake genomes already published. We discuss the future of snake genomics, pointing
out that new sequencing technologies will help overcome the problem of repetitive sequences in
assembling snake genomes. Genome sequences are also likely to be valuable in examining the
clustering of toxin genes on the chromosomes, in designing recombinant antivenoms and in studying
the epigenetic regulation of toxin gene expression.
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1. Introduction
The sequencing of animal genomes is uncovering a treasure trove of biological information.
Genomes can be defined in various ways. Functional definitions based on concepts of information-
encoding and transfer tend to ignore the role of extra-genomic (epigenetic) mechanisms in these
processes [1]. Therefore, we shall simply assume the genome to comprise the nucleotide sequence of
all nuclear and mitochondrial DNA of an organism. The genome may be sequenced in its entirety via
whole genome sequencing [2,3]. It may be more practical for some research questions to sequence
only the region of interest, using a ‘targeted capture’ approach [4]. Targeted approaches include the
selective sequencing of bacterial artificial chromosome (BAC) libraries [5].
Genome sequencing has tended to focus on Homo sapiens and there are reportedly plans to
sequence 2 million human genomes for biomedical research objectives including personalized
medicine [6]. Further, the genomes of many animal species used as models in biomedical research,
or reared in agriculture, have also been sequenced. The genomes of non-model species have received
far less attention although there are plans to sequence many thousands of vertebrate genome in the
near future [7].
1.1. Why Snakes Are Interesting
Snake genomics is a neglected topic, as can be seen by the relatively modest number of published
genomes and projects in the pipeline (Table 1). Nonetheless, it is a topic that is attracting increasing
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interest from a biologists in several sub-disciplines [8]. This interest in snake genomes stems from
the medical importance of snakebite in many developing countries [9], the potential for finding novel
drugs and other bioactive compounds in venoms [10] and, from the perspective of fundamental
research, the extraordinary array of evolutionary novelties found in snakes [11,12].
Table 1. Snake genome projects published or in progress.
Trivial Name Scientific Name Family Notes
Prong-snouted blind snake Anilios bituberculatus Typhlopidae F.J. Vonk et al., in progress
Texas blind snake Rena dulcis Leptotyphlopidae T.A. Castoe et al., in progress
Boa constrictor Boa constrictor Boidae Ref. [13]; GenB: PRJNA210004
Boa constrictor Boa constrictor Boidae Ref. [14]
Burmese python Python bivittatus Pythonidae Published [2]; GenB: AEQU00000000
Garter snake
Thamnophis sirtalis Colubridae GenB: LFLD00000000
Thamnophis elegans Colubridae Ref. [13]; GenB: PRJNA210004
Corn snake Pantherophis guttatus Colubridae Ref. [15]; GenB: JTLQ01000000
Corn snake Pantherophis guttatus Colubridae Targeted sequencing: 5′ hox genes [16]
King cobra Ophiophagus hannah Elapidae Published [3]; GenB: AZIM00000000
Malayan pit viper Calloselasma rhodostoma Viperidae F.J. Vonk et al., in progress
Five-pacer viper Deinagkistrodon acutus Viperidae Ref. [17]
European adder Vipera berus berus Viperidae
Baylor College of Medicine,
Human Genome Sequencing Center;
GenB: JTGP00000000
Habu Protobothropsflavoviridis Viperidae H. Shibata et al., in progress
Brown spotted pit viper Protobothropsmucrosquamatus Viperidae
A.S. Mikheyev et al., in progress;
GenB: PRJDB4386
Prairie rattlesnake Crotalus viridis viridis Viperidae T.A. Castoe et al., in progress
Western diamond-backed
rattlesnake Crotalus atrox Viperidae Ref. [5]
Timber rattlesnake Crotalus horridus Viperidae GenB: LVCR00000000.1
Speckled rattlesnake Crotalus mitchelliipyrrhus Viperidae Ref. [18]; GenB: JPMF01000000
Western Diamondback
rattlesnake, Mojave
rattlesnake and Eastern
Diamondback rattlesnake
Crotalus atrox,
C. scutulatus, and
C. adamanteus
Viperidae
Targeted sequencing of bacterial
artificial chromosome (BAC) clones
containing phospholipase A2 genes.
Pygmy rattlesnake Sistrurus miliarius Viperidae Ref. [13]; GenB: PRJNA210004
Temple pit viper Tropidolaemus wagleri Viperidae R.M. Kini et al., in progress
This list is not necessarily exhaustive. Abbreviation: GenB, GenBank accession number. Taxonomy according to
the Pubmed Taxonomy database [19].
Snakes (Serpentes) are represented by around 3000 extant species [20]. They show a suite of
adaptations common to many lineages of vertebrates that have independently evolved long, thin
bodies. This suite includes limb reduction or loss, axial elongation, increase in vertebral count and
asymmetry of paired viscera. Extant snakes have completely lost all traces of the forelimb and pectoral
girdle. In most species there is also loss of the hindlimb and pelvic girdle [11]. Exceptions include the
femoral and pelvic girdle remnants found on each side in Leptotyphlopidae (reviewed in Ref. [21]);
and the single pelvic element on each side in Typhlopidae [22]. Pelvic vestiges are also present in
Aniliidae, Cylindrophiidae and Anomochilidae; and in boas and pythons. There are both pelvic and
femoral vestiges, the latter often tipped with a horny spur [22,23]. Compared to ancestral squamates,
snakes show elongation of the primary axis with a high vertebral number and poor demarcation of the
vertebral regions [24]. The left lung is reduced in size or absent [25].
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Other adaptations include jaw modifications and metabolic adaptations associated with
swallowing prey whole [2]; the presence of a venom delivery system [26], consisting of the venom
glands and fangs; and heat-sensing “pit organs”. Venom delivery systems are found in approximately
600 species in the Elapidae, Viperidae, Colubridae and Atractaspididae [27]. Heat-sensitive pit organs
are represented by the loreal pit of Crotalinae [28], and the labial pits of some pythons and boas [29].
In the context of this special journal issue, the most relevant of these adaptations is venom, and the
peptide or protein toxins that it contains. Venom can be defined as any glandular secretion produced
by a metazoan that can be introduced into the tissues of another animal through a puncture (inflicted
by the venomous animal for that purpose) and which incapacitates prey or deters attackers by virtue
of its potent bioactivity [30]. Venom, and an associated venom delivery system (a gland connected to
a puncturing device), has evolved independently in many animal clades [31,32].
1.2. What Genomes Can Tell Us
As has been pointed out [33], toxin evolution has been studied for many years using traditional
sequencing and proteomics approaches; but new tools for genomics, transcriptomics and proteomics
are greatly advancing the field. For biomedical research in general, there are many advantages in
having genomic sequence data and we now summarize just a few of these advantages. A whole
genome sequence allows, in principle, the prediction of all translated genes (the exome) by means
of ab initio gene prediction algorithms [34] and homology searches using reference sequences [35].
Because of the paucity of genome sequences and the apparent frequent duplication of toxin-encoding
genes, the use of transcriptome data from the same species, or one closely related, makes this task
easier. The genes predicted may include genes for translated proteins as well as microRNAs (mRNAs)
and other non-coding genes.
Predicted gene sequences can then be used in a host of applications and analyses, ranging from
the design of probes for in situ hybridization [26], to searches for genes under positive or negative
selection, as inferred by the dN/dS ratio [36]. The latter analyses have shown that multiple genes are
under selection in snakes, or in clades within the snakes, including some venom toxin genes [3] and
developmental genes possibly connected to development of the serpentiform body plan [2].
With genome sequences, evolutionary gene loss can be more confidently asserted than by looking
at the transcriptome alone. Hypotheses about gene loss, or the degeneration of functional genes into
pseudogenes, can be more easily tested because non-coding pseudogenes can be identified in the
genome sequence on the basis of sequence homology or synteny [37]. Synteny refers to the location
of loci on the same chromosome, or the order and orientation of neighboring genes, especially when
compared across species [37].
Analysis of genome sequences shows that several visual pigment genes have been lost in snakes
compared with other squamates [2]. This may be related to the putative fossorial (burrowing) lifestyle
of an ancestral snake which might have had reduced eyes [38]. Genomics also reveals that some
neurotoxin genes have been lost in the lineage leading to the Western and Eastern diamond-backed
rattlesnakes (Crotalus atrox and C. adamanteus, respectively) [5].
Using genome sequences, it is possible to look for candidate regulatory regions; this in turn
may allow genomic regulatory blocks to be identified [39]. In the context of toxinology, it will
be especially interesting to examine whether duplicated toxin genes of the same toxin family are
clustered [5] and functionally part of a common regulatory landscape—in a way analogous, perhaps,
to the well-studied hox developmental genes [16]. Genome sequences allow the identification of
structural variations, including inversions, insertions, deletions and tandem duplications and other
large rearrangements [40]. It is also possible to look for transposable elements and other repetitive
sequences [41].
Genomic data can be used in phylogeny reconstruction (which is one aspect of the discipline
phylogenomics) although this endeavor is not without difficulties [37,42]. One such difficulty is that
the evolution of nucleotide sequences effectively overwrites the ancestral sequence making homologies
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(orthologues) more difficult to identify [37,42]. Horizontal gene transfer (between species), gene
loss and genome duplications [43] can further obscure the phylogenetic relationships among species
(reviewed in Ref. [37]).
1.3. Aims and Objectives of This Review
Our aim here is to review some of the biological results yielded, to date, by snake genomes; and to
consider some of the research questions that may one day be solved by the analysis of snake genomes.
We will focus mainly on the evolution of venom toxins, but discuss also some questions related to
snake morphological and physiological adaptations that are being illuminated by genomics.
2. Status of Snake Genome Sequencing Projects
The sequencing of snake genomes is very much in its infancy. The first draft genomes of
snakes to be published were those of the Boa constrictor (Boa constrictor) [13,14], Burmese python
(Python molurus bivittatus) [2] and the king cobra (Ophiophagus hannah) [3], followed by a high coverage
(238 ×) assembly of the first viper genome (Crotalus mitchellii) [18]. Some key data on the first two of
these draft genomes are summarized in Table 2. The status of some other snake genome projects
known to us, including studies based on targeted capture, is summarized in Table 1. As can be seen,
the genome sizes of the Burmese python [2] and king cobra [3] are 1.44 and 1.36–1.59 Gbp, respectively.
This is roughly half the size of the human genome and closer to the smaller genomes of some other
sauropsids such as the chicken and the anole lizard (Table 2).
Table 2. Selected data from the Burmese python and king cobra draft genomes and comparison with
genomes of other species.
Species Coding Genes (k) Genome Size (Gb) Repeats (%)
Burmese python 25 [2] 1.44 [2] 31.8–59.4 [2]
King cobra 21.19 [3] 1.36–1.59 [3] 35.2–60.4 [2]
Chicken 20–23 * [44] 1.05 [44] 4.3–8.0 [45]; 9.4 [44]
Human 20.4 ¶; 19 [46] 3.54 ¶ >66–69 [47]
Anolis 18.5 † 1.70 † 30% ‡ [48]
* v. 85.4 in ensembl.org gives the number of coding genes in the chicken genome as 15,508; ¶ Human genome,
build 38; ensembl.org; † GenBank Assembly ID GCA_000090745.1; ‡ Mobile elements.
3. Genome Data in the Reconstruction of Toxin Evolution
3.1. Overview of Possible Mechanisms of Toxin Evolution
Toxin evolution is reviewed in Ref. [32]. Waglerin toxins in Wagler’s viper (Tropidolaemus wagleri)
may well have arisen de novo since no orthologues have been found [49]. This is an exceptional case
and in general, the evolution of genes de novo is thought to be comparatively rare. Thus, in the human
genome, entirely new genes (i.e., those not found in other primates) are very few in number, and tend
not to be expressed in the proteome, suggesting that they function as non-protein-coding genes [46].
In fact, the likelihood of a gene being expressed in the human proteome at all was found to be related
to the age of evolutionary origin of that gene [46].
Cysteine-rich secretory protein (CRISP) and kallikrein toxins in Wagler’s viper are suggested
to have become toxic simply as a result of evolutionary changes in the coding sequence of existing
salivary proteins [49]. Indeed, another study concluded that not just a few, but in fact most, snake
venom toxins evolved from proteins expressed ancestrally in salivary glandular tissue [50]. In any
case, it is clear most venom toxins share close sequence similarity, at least in their functional domains,
with known, non-venom genes (physiological or body genes) [49].
Alternative splicing can result in both physiological and toxin isoforms being generated from
the same gene in different tissues. This appears to be the case with acetylcholinesterase gene of
Bungarus fasciatus [51].
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3.2. Moonlighting: The Strange Case of Nerve Growth Factor
Nerve growth factor (NGF) is a component of venoms in many snakes. At first sight, it may seem
to be nothing more than an innocuous neurotrophin apparently occurring in the venom for no good
reason. However, NGF is an extremely potent inducer of mast cell degranulation; thus it is possible
that it may produce increased local vascular permeability and toxin absorption; it may also produce or
enhance anaphylaxis [52,53]. The possibility that venom nerve growth factor may contribute to the
toxicity of venom is further suggested by the fact that, like other true venom toxins, it is under positive
selection in at least some snakes [52,53]. Nerve growth factor may also play an ancillary (non-toxic) role
while the venom is stored in the venom gland by inhibiting metalloprotease-mediated degradation [54].
Since a single isoform is present in Bothrops jararaca [55] it is possible that nerve growth factor may be
‘moonlighting’ as a venom component—that is, taking on functions in the venom additional to those of
its function as a neurotropin (the concept of moonlighting is discussed in Ref. [56]). However, arguing
against moonlighting is the fact that nerve growth factor is present in at least two copies in the king
cobra genome [3] and in other cobras (reviewed in Ref. [50]; see also Table 3 in the current article).
Table 3. Number of copies (paralogues) of toxin genes in the king cobra (Ophiophagus hannah) genome;
data from Ref. [3].
Venom Toxin or Toxin Family Number of Paralogues
3FTx (three-finger toxin) * 21
PLA2 (phospholipase A2) * 12
Lectin * 11
Kunitz * 10
Waprins * 6
Cystatin 5
CRISP (cysteine-rich secretory protein) 3
CVF (cobra venom factor) 3
Kallikrein 3
SVMP (snake venom metalloproteinase) 3
LAAO (L-amino acid oxidase) 2
NGF (nerve growth factor) 2
NP (natriuretic peptide) * 2
Acetylcholinesterase 1
Hyaluronidase 1
PLB (phospholipase-B) 1
VEGF (vascular endothelial growth factors) 1
Vespryn 1
Key: (*) estimated number of paralogues; the current genome assembly is not sufficiently well-scaffolded to
allow the number of paralogues to be determined with certainty.
3.3. Gene Duplication
Gene duplication may be important in the evolution of venom toxins at two levels: (i) in the origin
of the toxin gene from its ancestral counterpart and (ii) in subsequent expansion of the established
toxin gene into a multigene family.
Some toxin genes may have undergone an initial duplication event, after which one copy came to
be relatively highly expressed in the venom gland by some change in tissue-specific regulation [32].
The nascent toxin gene could then, in principle, undergo sequence evolution independently of its
non-venom paralogue to evolve a new function. This process is called neo-functionalization [57,58].
One problem with neo-functionalization as a mechanism is that mutations are more likely to
be deleterious than beneficial [59]. An alternative model of gene evolution after duplication is
sub-functionalization. This phenomenon can account for the survival of both paralogues because,
weakened in function by deleterious mutations, the two copies will need to be retained in the genome
in order to make up, together, the full ancestral function by virtue of their complementary effects [60].
This has been called the duplication-degeneration-complementation (DDC) hypothesis [60].
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There is no predictable pattern of duplication events in toxin evolution, as can be readily seen, for
example, in the highly variable number of different toxin paralogues in the king cobra genome (Table 3).
The number varies from one (hyaluronidase) to 21 (three-finger toxins). It is possible that some genes
have undergone what we have referred to as ‘hijacking’ [3]; that is, sequence modification without
duplication (Figure 1 in the current article). Comparative analysis of synteny (Figure 1) suggests that
the ancestral PLBD1 gene may have evolved into the king cobra venom phospholipase-B (PLB), and
that the HYALP1 gene similarly gave rise to venom-expressed hyaluronidase (HYAL).
An example of a gene that has undergone duplication is the ADAM gene which underwent
duplication and subsequently these duplicates evolved into a venom-expressed snake venom
metalloproteinase (SVMP) gene (Figure 1). Other toxins that have undergone multiple rounds of
duplication to produce multigene families include phospholipase A2 in rattlesnakes [5]. In that gene
family, some paralogues subsequently disappeared from the genome in different lineages, possibly
because of a change in prey type [5]. The origin of genes by duplication, and the subsequent loss of
some paralogues in this way, is consistent with the birth-and-death model of the evolution of multigene
families [61,62].
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found  in  the  green  anole  lizard  (Anolis  carolinensis)  and  the  chicken  (Gallus gallus)  results  in  the 
venom gland expressed phospholipase‐B (PLB). Note that PLB is found split across two king cobra 
genome scaffolds; (B) Modification of HYALP1 gene found in the mouse (Mus musculus) results in 
the  venom  gland  expressed  hyaluronidase  (HYAL);  (C)  Duplication  of  the  non‐venom  gland 
expressed  ADAM  gene  in  the  king  cobra  results  in  a  venom  gland  expressed  snake  venom 
Figure 1. Syntenic comparisons of venom genes in the king cobra with other vertebrates revealing
toxin recruitme t by hijacking/mo ification and gene upli atio . (A) Modification of PLBD1 gene
found in the green anole lizard (Anolis carolinensis) and the chicken (Gallus gallus) results in the venom
gland expressed phospholipase-B (PLB). Note that PLB is found split across two king cobra genome
scaffolds; (B) Modification of HYALP1 gene found in the mouse (Mus musculus) results in the venom
gland expressed hyaluronidase (HYAL); (C) Duplication of the non-venom gland expressed ADAM
gene in the king cobra results in a venom gland expressed snake venom metalloproteinase (SVMP)
gene. The ADAM gene in the green anole is flanked on both sides by non-SVMP genes, demonstrating
the absence of gene duplication in this species. Note that subsequent downstream duplication of the
SVMP gene in the king cobra results in multiple venom gland expressed SVMP isoforms. Based on
Figure S5 from [3].
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3.4. Possible Selective Advantage of Possessing Multigene Toxin Families
A preliminary analysis of the king cobra genome (Figure 2) suggests one possible selective
advantage of duplication in the evolution of multigene toxin families. There is a tendency for
paralogues that have undergone recent expansion to be more highly expressed in the venom gland
transcriptome. More work is required to confirm this hypothesis although it is consistent, for example,
with the relationship between amylase abundance and mRNA abundance in mice [63].
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Figure 2. Preliminary analysis of three finger toxin isoforms in the king cobra genome. (a) Phylogeny
showing isoform numbers; (b) Expression level (transcript abundance) in the venom gland; (c) Apparent
copy number in genome. One hypothesis consistent with the figure is that the more recently expanded
paralogues tend to be more highly expressed. The figure is an unpublished analysis by one of us
(Christiaan Henkel) base on data in R f. [3]. See Table 4 for corresponding genome sequencing and
accession codes of the three finger toxin isoforms.
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Other explanations for the evolution of multiple isoforms of the same toxin is that they might
provide broad spectrum toxicity against a range of prey species. Presumably, this is more likely to
be advantageous for generalists, than for specialists such as the king cobra. Multiple isoforms might
also provide potentiation, so that the toxin complex is more potent than a single toxin. Potentiation
is known, for example, in the cone snails [64]. The possession of multiple gene copies might make it
more difficult for prey to evolve resistance.
Table 4. King cobra three finger toxin genome sequencing and accession codes. Isoforms correspond
with the ones referred to in Figure 2.
3FTX Isoform Nucleotide Sequence Accession Code Genbank
Iso1 GATACACCTTGACATGTCTAACACATGAATCATTATTTTTTGAAACCACTGAGACTTGTTCAGATGGGCAGAACCTATGCTATGCAAAATGGTTTGCAGTTTTTCCAGGTG AZIM01011044.1
Iso2 GATACACCAGGATATGCCACAAATCTTCTTTTATCTCTGAGACTTGTCCAGATGGGCAGAACCTATGCTATTTAAAATCGTGGTGTGACATTTTTT AZIM01016929.1
Iso3 GATACACCTTGACATGCATCACATCTGCTCGTAACTTTGAGACTTGTCCACCTGGGCAGAACCTATGCTTTTTAAAATCATGGTATGAAGCTTCAT AZIM01214498.1
Iso4 TACAAAACCGGTGAACGTATTATTTCTGAGACTTGTCCCCCTGGGCAGGACCTATGCTATATGAAGACTTGGTGTGACGTTTTTT AZIM01146344.1
Iso5 GATACACCATGACATGTTACACACAGTACTCATTGTCTCCTCCAACCACTAAGACTTGTCCAGATGGGCAGAACCTATGCTATAAAAGGTGATTTGCGTTTATTCCACATG AZIM01015434.1
Iso6 GATACACCACGAAATGCTACGTAACACCTGATGCTACCTCTCAGACTTGTCCAGATGGGGAGAACATATGCTATACAAAGTCTTGGTGTGACGGTTTTT AZIM01133918.1
Iso7 GATACACCACGAAATGCTATGTAACACCTGATGCTACCTCTCAGACTTGTCCAGATGGGGAGAACATATGCTATACAAAGTCTTGGTGTGACGTTTTTT AZIM01229389.1
Iso8 GATACACCACGAAATGCTACATAACACCTGATGTGAAGTCTCAGACTTGTCCAGATGGGGAGAACATATGCTATACAAAGACTTGGTGTGATGTTTGGT AZIM01229389.1
Iso9 GATACACCACGAAATGCTACGTAACACCTGATGTTAAGTCTGAGACTTGTCCAGATGGGCAGGACATATGCTATACAGAGACTTGGTGTGACGTTTGGT AZIM01028336.1
Iso10 GATACACCACGAAATGCTACGTAACACCTGATGTTAAGTCTGAGACTTGTCCAGCTGGGCAGGACATATGCTATACAGAGACTTGGTGTGATGCTTGGT AZIM01097792.1
Iso11 GACACACCAGGATATGTCTCACAGACTACTCAAAAGTTAGTGAAACCATTGAGATTTGTCCAGATGGGCAGAACTTCTGCTTTAAAAAGTTTCCTAAGGGTATTCCATTTT AZIM01006046.1
Iso12 GATACACCATGAAATGTCTCACAAAGTACTCCCGGGTTAGTGAAACCTCTCAGACTTGTCACGTTTGGCAGAACCTATGTTTTAAAAAGTGGCAGAAGG AZIM01011575.1
Iso13 GACACACCTTGATATGTGTCAAACAGTACACAATTTTTGGTGTAACCCCTGAGATTTGCGCAGATGGGCAGAACCTATGCTATAAAACATGGCATATGGTGTATCCAGGTG AZIM01011969.1
Iso14 GATACACCACGAAATGTTACAACCACCAGTCAACGACTCCTGAAACCACTGAAATTTGTCCAGATTCAGGGTACTTTTGCTATAAAAGCTCTTGGATTGATGGACGTG AZIM01034614.1
Iso15 GATACACCCTGATATGTCACCGAGTGCATGGACTTCAGACTTGTGAACCAGATGAGAAGTTTTGCTTTAGAAAGACGACAATGTTTTTTCCAAATC AZIM01009352.1
Iso16 GATACACCAGGAAATGTCTCAACACACCGCTTCCTTTGATCTATANTTAAAATGACTATTAAGAAGTTGCCATCTA AZIM01009586.1
Iso17 NATACACCAGGATATGTTTAAAGCAAGAGCCATTTCAACCTGAAACCAGTACAACTTGTCCAGATGGGGAAGATGCTTGCTATAGTACATTTTGGAGTGATAACC AZIM01019523.1
Iso18 NATACACCAGGATATGTTTAAAGCAAGAGCCGTTTCAACCTGAAACCACTACAACTTGTCCAGAAGGGGAGGATGCTTGCTATAATTTGTTTTGGAGTGATCACA AZIM01052732.1
Iso19 GATACAGCTTGATATGTTTTAACCAAGAGACGTATCGACCTGAAACCACTACAACTTGTCCAGATGGGGAGGACACTTGCTATAGTACATTTTGGAATGATCACCATG AZIM01009977.1
Iso20 CACAAACCAAGACATGTTACTCATGCACTGGAGCATTTTGTTCTAATCGTCAAAAATGTTCGGGTGGGCAGGTCATATGCTTTAAAAGTTGGAAAAATACTCTTCTGATAT AZIM01013260.1
Iso21 CACACACCCTGACATGTTACTCATGCAATGGATTATTATGTTCTGACCGTGAACAATGTCCAGATGGGTAGGACATATGCTTTAAGAGATGGAATGATACTGATTGGTCAG AZIM01013561.1
Iso22 GATACAGCTTGACATGTCTCAATTGCCCAGAACAGTATTGTAAAAGAATTCACACTTGTCGAGATGGGGAGAACGTATGCTTTAAAAGGTTTTACGAGGGTAAACTATTAT AZIM01071124.1
Iso23 GATACACTCTGTTGTGTTGCAAATGCAATCAAACGGTTTGTGATCTCAATTCGTATTGTTCAGCAGGCAAGAACCAATGCTATATATTGCAGAATAATA AZIM01008565.1
3.5. The Selective Expression of Toxin Genes, or Their Ancestral Orthologues, in the Venom Gland
Given that many toxins have arisen by duplication from genes whose ancestral function was
something other than that of a venom toxin [5,49,55,65], how did one or more of the duplicates
(paralogues) come to be selectively expressed in the venom gland?
3.5.1. Recruitment and Neo-Functionalisation Hypothesis
One scenario for the selective expression of toxin genes in the venom gland is as follows [49].
One of the copies of the ancestral gene underwent a change in tissue-specific regulation so as to
become expressed de novo in the venom gland [66]. This paralogue then underwent evolution of
its coding sequence so as to become more effective as a venom toxin [3]. Such adaptive changes in
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the coding sequence of the newly-recruited gene represent “neo-functionalization”—the evolution
of a function not related to the ancestral function (reviewed in Ref. [57,58]). Changes in the coding
sequence may be accompanied by additional changes in the regulation of toxin gene transcription,
as well as in translation and post-translational modification of the protein [67]. Finally, there is evidence
that a toxin gene may ultimately undergo a further change in tissue-specific regulation and revert to
being expressed in a tissue or organ other than the venom gland [55,68]. While this hypothesis has
been disputed [69], recent work comparing toxin expression in multiple different tissues of B. jararaca
provided additional evidence for reverse recruitment [55].
3.5.2. Restriction and Sub-Functionalisation Hypothesis
The hypothesis of duplication and neo-functionalisation outlined above has been questioned [50]
on the grounds that gene duplication in vertebrate genomes is an extremely rare event, and that
persuasive examples of neo-functionalisation have rarely been described in any context. Furthermore,
since new transcriptional regulatory relations have to be established for a gene to become highly
expressed in the venom gland, the whole scenario is argued to be improbable [50].
An alternative hypothesis is that the ancestral gene was expressed in a wide range of tissues,
including the venom gland; it then underwent duplication, with one paralogue becoming restricted
in expression to the venom gland and losing expression in the other tissues [50]. Thus, while the
recruitment and neo-functionalisation hypothesis is critically dependent on the acquisition of new
regulatory regions (for the novel expression of a paralogue in the venom gland), the recruitment and
sub-functionalisation depends on the loss of regulatory regions (that ancestrally drove expression in
tissues other than the venom gland).
3.5.3. Testing the Recruitment and Restriction Hypotheses
It may well prove to be difficult or impossible to test these hypotheses using comparative
transcriptomic data only. An essential pre-requisite will be the availability of multiple snake genomes
that provide appropriate taxon sampling, together with the identification of regulatory regions that
control the tissue-specific expression of toxin genes and their ancestral paralogues. Putative regulatory
sequences will also have to be tested functionally. Progress is being made in this area, as we shall
now discuss.
3.6. Mechanisms of Transcriptional Regulation That Might Have Led to Selective Expression of Toxin Genes in
the Venom-Gland
3.6.1. Non-Coding RNA Genes
RPTLN are long, non-coding RNA genes that may have been involved in the evolution of
snake venom metalloproteinases (SVMPs) from a disintegrin and metalloproteinase (ADAM) gene.
According to one hypothesis [66], RPTLN was under the control of a venom gland promotor and
its signal sequence became fused with the extracellular domain of the one copy of the ancestrally
physiological ADAM gene (the latter having previously undergone tandem duplication). After thus
being activated in the venom gland, the ADAM gene evolved into an SVMP [66]. The authors note that
their hypothesis can be tested as soon as genome builds for the relevant snake species are available
(see also this issue: see Ref. [70] for more information).
3.6.2. Transposable Elements
Another intriguing possibility is that CR1 LINE transposable elements, which are much more
abundant in advanced than in basal snakes, may have played a role in toxin gene recruitment [2].
CR1 LINEs are abundant in the genome of the copperhead (Agkistrodon contortrix)—much more
abundant than they are in the Burmese python (Python molurus bivittatus) genome [41]. We discuss
transposable elements and other repetitive sequences in more detail below.
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3.6.3. VERSE
It has previously been shown that the gene sequences of TroD (venom prothrombin activator gene)
and TrFX (blood coagulation factor X gene) are highly similar, except for promoter and intron 1 regions,
indicating that TroD probably evolved by duplication of its plasma counterpart [22]. The insertion,
in the promoter of TroD, of a VERSE sequence (VEnom Recruitment/Switch Element) accounts for
elevated, but not tissue-specific, expression [23].
3.6.4. AG-Rich Motifs
More recently, it was found that AG-rich motifs, in the first intron, silence gene expression
in non-venom gland tissues [71]. These AG-rich motifs are promotor-independent silencers, and
such cis-elements are also found in some snake toxin genes, but not in housekeeping genes.
Several polycomb group proteins (transcription factors) were identified to bind these motifs to regulate
expression. Genome sequences will help in identifying regulatory elements that control tissue-specific
expression of toxin genes in venom glands as well as expression of cognate genes in respective tissues.
3.7. Evolution of Toxin Resistance in Snakes as Studied with Genomic Data
Genome sequences have cast light on the resistance by snakes to the toxins of their prey.
Thus, the Eastern hog-nosed snake (Heterodon platirhinos) is resistant to the tetrodotoxin of
Notophthalmus viridescens a newt on which it preys [72], and the garter snake Thamnophis sirtalis
likewise shows resistance to the neurotoxic tetrodotoxin of newts in the genus Taricha [73]. Tetrodotoxin
resistance in Thamnophis is due to modification of the amino acid sequence of tetrodotoxin targets:
sodium ion channels on skeletal muscles (Nav1.4) and peripheral neurons (Nav1.6 and Nav1.7;
reviewed in Refs. [73,74]). Analysis of snake genomic data and partial sequences, suggests that
tetrodotoxin resistance in Thamnophis arose stepwise over a long period of evolutionary time, with
the ancient modifications of the sodium channels in nerves providing the necessary conditions for
evolution of resistance in skeletal muscle sodium-channels [73].
4. Transposable Elements and Other Repetitive Sequences in Snake Genomes
Repetitive elements (repeats) are DNA sequences present in many copies in a genome; they can be
classified into tandem repeats and transposable elements [75]. They are relatively abundant in snake
genomes, especially the genomes of advanced snakes.
Studies of snake genomes have shown how transposable elements have accumulated in the
Hox complex of developmental genes. The Hox complex consists of transcription factor genes that
have important roles in regulating embryonic pattern formation. Di-Poï and colleagues selectively
sequenced the 5′ regions of the Hox clusters of different species [6]. In the squamates studied, including
the corn snake (Pantherophis guttatus) the clusters had become expanded in size due the accumulation of
numerous transposable elements. These transposons include retrotransposons and DNA transposons,
and occur mainly in the introns and intergenic regions [6]. The availability of genomic sequences is
also helping to uncover possible incidences of horizontal gene transfer. Thus, the long interspersed
element (LINE) non-LTR retrotransposon BovB is suggested to have been transferred, by tics, from
squamates to bovids [28].
5. Future Prospects in Snake Genomics
In the future, it may be possible to scan snake genomes for bioactive molecules; this could be
done, for example, by comparison with a pharmacophore database. Drug discovery from venoms
has already delivered drugs such as Prialt, Integrilin, Captopril and Byetta, and multiple candidates
are now progressing in clinical trials [76,77]. Furthermore, peptides derived from venoms are valid
pharmacological tools to study diseases [78]. For example, the study of the snake toxin α-bungarotoxin
led to characterisation of the nicotinic acetylcholine receptor (nAChR) and a new understanding
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of the disease myasthenia gravis [79]. Genome sequences also provide the prospect of generating
recombinant antivenoms [80]. Additionally, methylome sequencing will allow us to investigate the
role of epigenetics in regulating toxin gene expression [81].
Another step forward in snake genome sequencing will be new sequencing techniques. Next- or
second-generation sequencing, so-called because of the advance in Sanger sequencing, produces
short reads with low error rates and high throughput [82]. Examples of next-generation platforms
are Illumina and Roche 454. The newly-emerging third-generation sequencing platforms are able to
provide reads many kB long [83,84]. These platforms include the so-called “PacBio” system—single
molecule, real-time (SMRT) sequencing—from Pacific Biosciences; and MinION™ from Oxford
Nanopore Technologies [82]. MinION™ has a higher error rate than PacBio [82] and both have
higher error rates than second-generation sequencing. For a review of different sequencing platforms
and their properties, see Ref. [84].
Given the relatively high percentage of repetitive sequences in advanced snake genomes, a hybrid
approach is very promising, and has indeed proved useful for the tackling the same problem in the
human genome [84]. This approach involves using the long reads of third-generation sequencing to
bridge the gaps due to repeats; and combining them with reads from second-generation sequencing
to ameliorate the problem of errors in the long reads [84]. We have used this approach to assemble
a draft genome of the Malayan pit viper (unpublished data). However, as the error rate of long-read
sequencing improves, the hybrid approach will likely lose favor.
Other interesting developments in sequencing include optical mapping [85], useful for examining
the large-scale organization of genomic features, especially around large repetitive clusters; and
single-cell RNA-seq [86]. The latter would be very useful in investigating the regulation of toxin
production in the venom gland, as it provides a transcriptomic profile per individual cell (and thereby
an overview of the different cell types in a gland).
Acknowledgments: We thank Nicholas Casewell for reading the manuscript. Any errors are ours and not his.
We are also grateful to Todd Castoe, Naoko Oda-Ueda and Kim Worley for helpful discussions.
Author Contributions: All authors contributed ideas, comments and references to this article. H.M.I.K. and
M.K.R. took the lead in writing and structuring the article. H.M.I.K. and C.V.H. made the figures.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. Goldman, A.D.; Landweber, L.F. What is a genome? PLoS Genet. 2016, 12. [CrossRef] [PubMed]
2. Castoe, T.A.; de Koning, A.P.; Hall, K.T.; Card, D.C.; Schield, D.R.; Fujita, M.K.; Ruggiero, R.P.; Degner, J.F.;
Daza, J.M.; Gu, W.; et al. The burmese python genome reveals the molecular basis for extreme adaptation in
snakes. Proc. Natl. Acad. Sci. USA 2013, 110, 20645–20650. [CrossRef] [PubMed]
3. Vonk, F.J.; Casewell, N.R.; Henkel, C.V.; Heimberg, A.M.; Jansen, H.J.; McCleary, R.J.; Kerkkamp, H.M.;
Vos, R.A.; Guerreiro, I.; Calvete, J.J.; et al. The king cobra genome reveals dynamic gene evolution and
adaptation in the snake venom system. Proc. Natl. Acad. Sci. USA 2013, 110, 20651–20656. [CrossRef]
[PubMed]
4. Jones, M.R.; Good, J.M. Targeted capture in evolutionary and ecological genomics. Mol. Ecol. 2016, 25,
185–202. [CrossRef] [PubMed]
5. Dowell, N.L.; Giorgianni, M.W.; Kassner, V.A.; Selegue, J.E.; Sanchez, E.E.; Carroll, S.B. The deep origin and
recent loss of venom toxin genes in rattlesnakes. Curr Biol 2016, 26, 2434–2445. [CrossRef] [PubMed]
6. Ledford, H. Astrazeneca launches project to sequence 2 million genomes. Nature 2016, 532. [CrossRef]
[PubMed]
7. Koepfli, K.P.; Paten, B.; O’Brien, S.J. The genome 10K project: A way forward. Annu. Rev. Anim. Biosci. 2015,
3, 57–111. [CrossRef] [PubMed]
Toxins 2016, 8, 360 12 of 15
8. Schield, D.R.; Card, D.C.; Reyes-Velasco, J.; Andrew, A.L.; Modahl, C.A.; Mackessy, S.M.; Pollock, D.D.;
Castoe, T.A. A role for genomics in rattlesnake research—Current knowledge and future potential.
In Rattlesnakes of Arizona; Schuett, G.W., Porras, L.W., Reiserer, R.S., Eds.; Eco Books: Rodeo, NM, USA,
in press.
9. World Health Organization. Rabies and Envenomings: A Neglected Public Health Issue: Report of a Consultative
Meeting, World Health Organization, Geneva, 10 January 2007; World Health Organization: Geneva,
Switzerland, 2007.
10. Vonk, F.J.; Jackson, K.; Doley, R.; Madaras, F.; Mirtschin, P.J.; Vidal, N. Snake venom: From fieldwork to the
clinic: Recent insights into snake biology, together with new technology allowing high-throughput screening
of venom, bring new hope for drug discovery. Bioessays 2011, 33, 269–279. [CrossRef] [PubMed]
11. Coates, M.; Ruta, M. Nice snake, shame about the legs. Trends Ecol. Evol. 2000, 15, 503–507. [CrossRef]
12. Greene, H.W. Snakes: The Evolution of Mystery in Nature; University of California Press: Berkeley, CA, USA,
1997; p. 351.
13. Vicoso, B.; Emerson, J.J.; Zektser, Y.; Mahajan, S.; Bachtrog, D. Comparative sex chromosome genomics in
snakes: Differentiation, evolutionary strata, and lack of global dosage compensation. PLoS Biol. 2013, 11.
[CrossRef] [PubMed]
14. Bradnam, K.R.; Fass, J.N.; Alexandrov, A.; Baranay, P.; Bechner, M.; Birol, I.; Boisvert, S.; Chapman, J.A.;
Chapuis, G.; Chikhi, R.; et al. Assemblathon 2: Evaluating de novo methods of genome assembly in
three vertebrate species. Gigascience 2013, 2. [CrossRef] [PubMed]
15. Ullate-Agote, A.; Milinkovitch, M.C.; Tzika, A.C. The genome sequence of the corn snake (Pantherophis
guttatus), a valuable resource for evodevo studies in squamates. Int. J. Dev. Biol. 2014, 58, 881–888. [CrossRef]
[PubMed]
16. Di-Poi, N.; Montoya-Burgos, J.I.; Miller, H.; Pourquie, O.; Milinkovitch, M.C.; Duboule, D. Changes in hox
genes’ structure and function during the evolution of the squamate body plan. Nature 2010, 464, 99–103.
[CrossRef] [PubMed]
17. Yin, W.; Wang, Z.; Li, Q.; Lian, J.; Zhou, Y.; Lu, B.; Jin, L.; Qiu, P.; Zhang, P.; Zhu, W.; et al. Evolution
trajectories of snake genes and genomes revealed by comparative analyses of five-pacer viper. Nat. Commun.
2016, 7. [CrossRef] [PubMed]
18. Gilbert, C.; Meik, J.M.; Dashevsky, D.; Card, D.C.; Castoe, T.A.; Schaack, S. Endogenous hepadnaviruses,
bornaviruses and circoviruses in snakes. Proc. R. Soc. 2014, 281. [CrossRef] [PubMed]
19. Pubmed taxonomy database. Available online: https://www.Ncbi.Nlm.Nih.Gov/taxonomy (accessed on
30 November 2016).
20. Vidal, N.; Delmas, A.S.; David, P.; Cruaud, C.; Couloux, A.; Hedges, S.B. The phylogeny and classification
of caenophidian snakes inferred from seven nuclear protein-coding genes. C. R. Biol. 2007, 330, 182–187.
[CrossRef] [PubMed]
21. Pinto, R.R.; Martins, A.R.; Curcio, F.; Ramos, L.O. Osteology and cartilaginous elements of trilepida salgueiroi
(amaral, 1954) (scolecophidia: Leptotyphlopidae). Anat. Rec. (Hoboken) 2015, 298, 1722–1747. [CrossRef]
[PubMed]
22. Boulenger, G.A. Catalogue of the Snakes in the British Museum (Natural History); British Museum (Natural
History): London, UK, 1893; Volume 1, p. 448.
23. Cohn, M.J.; Tickle, C. Developmental basis of limblessness and axial patterning in snakes. Nature 1999, 399,
474–479. [CrossRef] [PubMed]
24. Head, J.J.; Polly, P.D. Evolution of the snake body form reveals homoplasy in amniote hox gene function.
Nature 2015, 520, 86–89. [CrossRef] [PubMed]
25. Van Soldt, B.J.; Metscher, B.D.; Poelmann, R.E.; Vervust, B.; Vonk, F.J.; Muller, G.B.; Richardson, M.K.
Heterochrony and early left-right asymmetry in the development of the cardiorespiratory system of snakes.
PLoS ONE 2015, 10. [CrossRef] [PubMed]
26. Vonk, F.J.; Admiraal, J.F.; Jackson, K.; Reshef, R.; de Bakker, M.A.; Vanderschoot, K.; van den Berge, I.;
van Atten, M.; Burgerhout, E.; Beck, A.; et al. Evolutionary origin and development of snake fangs. Nature
2008, 454, 630–633. [CrossRef] [PubMed]
27. Jackson, K. Evolution of the venom conducting fang in snakes. Integr. Comp. Biol. 2002, 42, 1249.
Toxins 2016, 8, 360 13 of 15
28. Hofstadler Deiques, C. The development of the pit organ of bothrops jararaca and crotalus durissus terrificus
(serpentes, viperidae): Support for the monophyly of the subfamily crotalinae. Acta Zool. 2002, 83, 175–182.
[CrossRef]
29. Gracheva, E.O.; Ingolia, N.T.; Kelly, Y.M.; Cordero-Morales, J.F.; Hollopeter, G.; Chesler, A.T.; Sanchez, E.E.;
Perez, J.C.; Weissman, J.S.; Julius, D. Molecular basis of infrared detection by snakes. Nature 2010, 464,
1006–1011. [CrossRef] [PubMed]
30. Weinstein, S.A. Snake venoms: A brief treatise on etymology, origins of terminology, and definitions. Toxicon
2015, 103, 188–195. [CrossRef] [PubMed]
31. Fry, B.G.; Roelants, K.; Champagne, D.E.; Scheib, H.; Tyndall, J.D.; King, G.F.; Nevalainen, T.J.; Norman, J.A.;
Lewis, R.J.; Norton, R.S.; et al. The toxicogenomic multiverse: Convergent recruitment of proteins into
animal venoms. Annu. Rev. Genom. Hum. Genet. 2009, 10, 483–511. [CrossRef] [PubMed]
32. Casewell, N.R.; Wuster, W.; Vonk, F.J.; Harrison, R.A.; Fry, B.G. Complex cocktails: The evolutionary novelty
of venoms. Trends Ecol. Evol. 2013, 28, 219–229. [CrossRef] [PubMed]
33. Reyes-Velasco, J.; Card, D.C.; Andrew, A.L.; Shaney, K.J.; Adams, R.H.; Schield, D.R.; Casewell, N.R.;
Mackessy, S.P.; Castoe, T.A. Expression of venom gene homologs in diverse python tissues suggests a new
model for the evolution of snake venom. Mol. Biol. Evol. 2015, 32, 173–183. [CrossRef] [PubMed]
34. Majoros, W.H.; Pertea, M.; Salzberg, S.L. Tigrscan and glimmerhmm: Two open source ab initio eukaryotic
gene-finders. Bioinformatics 2004, 20, 2878–2879. [CrossRef] [PubMed]
35. Collins, J.E.; White, S.; Searle, S.M.; Stemple, D.L. Incorporating RNA-seq data into the zebrafish ensembl
genebuild. Genome Res. 2012, 22, 2067–2078. [CrossRef] [PubMed]
36. Spielman, S.J.; Wan, S.; Wilke, C.O. A comparison of one-rate and two-rate inference frameworks for
site-specific dn/ds estimation. Genetics 2016, 24, 2499–2511. [CrossRef] [PubMed]
37. Tekaia, F. Inferring orthologs: Open questions and perspectives. Genom. Insights 2016, 9, 17–28. [CrossRef]
[PubMed]
38. Simoes, B.F.; Sampaio, F.L.; Jared, C.; Antoniazzi, M.M.; Loew, E.R.; Bowmaker, J.K.; Rodriguez, A.; Hart, N.S.;
Hunt, D.M.; Partridge, J.C.; et al. Visual system evolution and the nature of the ancestral snake. J. Evol. Biol.
2015, 28, 1309–1320. [CrossRef] [PubMed]
39. Irimia, M.; Maeso, I.; Roy, S.W.; Fraser, H.B. Ancient cis-regulatory constraints and the evolution of genome
architecture. Trends Genet. 2013, 29, 521–528. [CrossRef] [PubMed]
40. Tattini, L.; D’Aurizio, R.; Magi, A. Detection of genomic structural variants from next-generation sequencing
data. Front. Bioeng. Biotechnol. 2015, 3. [CrossRef] [PubMed]
41. Castoe, T.A.; Hall, K.T.; Mboulas, M.L.G.; Gu, W.; de Koning, A.P.; Fox, S.E.; Poole, A.W.; Vemulapalli, V.;
Daza, J.M.; Mockler, T.; et al. Discovery of highly divergent repeat landscapes in snake genomes using
high-throughput sequencing. Genome Biol. Evol. 2011, 3, 641–653. [CrossRef] [PubMed]
42. Telford, M.J.; Copley, R.R. Improving animal phylogenies with genomic data. Trends Genet. 2011, 27, 186–195.
[CrossRef] [PubMed]
43. Taylor, J.S.; Van de Peer, Y.; Braasch, I.; Meyer, A. Comparative genomics provides evidence for an ancient
genome duplication event in fish. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2001, 356, 1661–1679. [CrossRef]
[PubMed]
44. Hillier, L.W.; Miller, W.; Birney, E.; Warren, W.; Hardison, R.C.; Ponting, C.P.; Bork, P.; Burt, D.W.;
Groenen, M.A.; Delany, M.E.; et al. Sequence and comparative analysis of the chicken genome provide
unique perspectives on vertebrate evolution. Nature 2004, 432, 695–716. [CrossRef] [PubMed]
45. Wicker, T.; Robertson, J.S.; Schulze, S.R.; Feltus, F.A.; Magrini, V.; Morrison, J.A.; Mardis, E.R.; Wilson, R.K.;
Peterson, D.G.; Paterson, A.H.; et al. The repetitive landscape of the chicken genome. Genome Res. 2005, 15,
126–136. [CrossRef] [PubMed]
46. Ezkurdia, I.; Juan, D.; Rodriguez, J.M.; Frankish, A.; Diekhans, M.; Harrow, J.; Vazquez, J.; Valencia, A.;
Tress, M.L. Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding
genes. Hum. Mol. Genet. 2014, 23, 5866–5878. [CrossRef] [PubMed]
47. De Koning, A.P.; Gu, W.; Castoe, T.A.; Batzer, M.A.; Pollock, D.D. Repetitive elements may comprise over
two-thirds of the human genome. PLoS Genet. 2011, 7. [CrossRef] [PubMed]
48. Alfoldi, J.; Di Palma, F.; Grabherr, M.; Williams, C.; Kong, L.; Mauceli, E.; Russell, P.; Lowe, C.B.; Glor, R.E.;
Jaffe, J.D.; et al. The genome of the green anole lizard and a comparative analysis with birds and mammals.
Nature 2011, 477, 587–591. [CrossRef] [PubMed]
Toxins 2016, 8, 360 14 of 15
49. Fry, B.G. From genome to “venome”: Molecular origin and evolution of the snake venom proteome inferred
from phylogenetic analysis of toxin sequences and related body proteins. Genome Res. 2005, 15, 403–420.
[CrossRef] [PubMed]
50. Hargreaves, A.D.; Swain, M.T.; Hegarty, M.J.; Logan, D.W.; Mulley, J.F. Restriction and recruitment-gene
duplication and the origin and evolution of snake venom toxins. Genome Biol. Evol. 2014, 6, 2088–2095.
[CrossRef] [PubMed]
51. Cousin, X.; Bon, S.; Massoulie, J.; Bon, C. Identification of a novel type of alternatively spliced exon from the
acetylcholinesterase gene of bungarus fasciatus. Molecular forms of acetylcholinesterase in the snake liver
and muscle. J. Biol. Chem. 1998, 273, 9812–9820. [CrossRef] [PubMed]
52. Sunagar, K.; Fry, B.G.; Jackson, T.N.; Casewell, N.R.; Undheim, E.A.; Vidal, N.; Ali, S.A.; King, G.F.;
Vasudevan, K.; Vasconcelos, V.; et al. Molecular evolution of vertebrate neurotrophins: Co-option of
the highly conserved nerve growth factor gene into the advanced snake venom arsenalf. PLoS ONE 2013, 8.
[CrossRef]
53. Kostiza, T.; Meier, J. Nerve growth factors from snake venoms: Chemical properties, mode of action and
biological significance. Toxicon 1996, 34, 787–806. [CrossRef]
54. Wijeyewickrema, L.C.; Gardiner, E.E.; Gladigau, E.L.; Berndt, M.C.; Andrews, R.K. Nerve growth
factor inhibits metalloproteinase-disintegrins and blocks ectodomain shedding of platelet glycoprotein
vi. J. Biol. Chem. 2010, 285, 11793–11799. [CrossRef] [PubMed]
55. Junqueira-de-Azevedo, I.L.; Bastos, C.M.; Ho, P.L.; Luna, M.S.; Yamanouye, N.; Casewell, N.R. Venom-related
transcripts from bothrops jararaca tissues provide novel molecular insights into the production and evolution
of snake venom. Mol. Biol. Evol. 2015, 32, 754–766. [CrossRef] [PubMed]
56. Jeffery, C.J. Protein species and moonlighting proteins: Very small changes in a protein’s covalent structure
can change its biochemical function. J. Proteom. 2016, 134, 19–24. [CrossRef] [PubMed]
57. True, J.R.; Carroll, S.B. Gene co-option in physiological and morphological evolution. Annu. Rev. Cell
Dev. Biol. 2002, 18, 53–80. [CrossRef] [PubMed]
58. Taylor, J.S.; Raes, J. Duplication and divergence: The evolution of new genes and old ideas. Annu. Rev. Genet.
2004, 38, 615–643. [CrossRef] [PubMed]
59. Loewe, L.; Hill, W.G. The population genetics of mutations: Good, bad and indifferent. Philos. Trans. R. Soc.
B Biol. Sci. 2010, 365, 1153–1167. [CrossRef] [PubMed]
60. Force, A.; Lynch, M.; Pickett, F.B.; Amores, A.; Yan, Y.L.; Postlethwait, J. Preservation of duplicate genes by
complementary, degenerative mutations. Genetics 1999, 151, 1531–1545. [PubMed]
61. Fry, B.G.; Wuster, W.; Kini, R.M.; Brusic, V.; Khan, A.; Venkataraman, D.; Rooney, A.P. Molecular evolution
and phylogeny of elapid snake venom three-finger toxins. J. Mol. Evol. 2003, 57, 110–129. [CrossRef]
[PubMed]
62. Nei, M.; Rooney, A.P. Concerted and birth-and-death evolution of multigene families. Annu. Rev. Genet.
2005, 39, 121–152. [CrossRef] [PubMed]
63. Meisler, M.H.; Antonucci, T.K.; Treisman, L.O.; Gumucio, D.L.; Samuelson, L.C. Interstrain variation in
amylase gene copy number and mRNA abundance in three mouse tissues. Genetics 1986, 113, 713–722.
[PubMed]
64. Olivera, B.M.; Seger, J.; Horvath, M.P.; Fedosov, A.E. Prey-capture strategies of fish-hunting cone snails:
Behavior, neurobiology and evolution. Brain Behav. Evol. 2015, 86, 58–74. [CrossRef] [PubMed]
65. Fry, B.G.; Vidal, N.; Norman, J.A.; Vonk, F.J.; Scheib, H.; Ramjan, S.F.; Kuruppu, S.; Fung, K.; Hedges, S.B.;
Richardson, M.K.; et al. Early evolution of the venom system in lizards and snakes. Nature 2006, 439, 584–588.
[CrossRef] [PubMed]
66. Sanz-Soler, R.; Sanz, L.; Calvete, J.J. Distribution of rptln genes across reptilia: Hypothesized role for rptln in
the evolution of svmps. Integr. Comp. Biol. 2016. [CrossRef] [PubMed]
67. Casewell, N.R.; Wagstaff, S.C.; Wuster, W.; Cook, D.A.; Bolton, F.M.; King, S.I.; Pla, D.; Sanz, L.; Calvete, J.J.;
Harrison, R.A. Medically important differences in snake venom composition are dictated by distinct
postgenomic mechanisms. Proc. Natl. Acad. Sci. USA 2014, 111, 9205–9210. [CrossRef] [PubMed]
68. Casewell, N.R.; Huttley, G.A.; Wuster, W. Dynamic evolution of venom proteins in squamate reptiles.
Nat. Commun. 2012, 3. [CrossRef] [PubMed]
Toxins 2016, 8, 360 15 of 15
69. Hargreaves, A.D.; Swain, M.T.; Logan, D.W.; Mulley, J.F. Testing the toxicofera: Comparative transcriptomics
casts doubt on the single, early evolution of the reptile venom system. Toxicon 2014, 92, 140–156. [CrossRef]
[PubMed]
70. Sanz, L.; Calvete, J.J. Insights into the evolution of a snake venom multi-gene family from the genomic
organization of echis ocellatus svmp genes. Toxins (Basel) 2016, 8. [CrossRef] [PubMed]
71. Han, S.X.; Kwong, S.; Ge, R.; Kolatkar, P.R.; Woods, A.E.; Blanchet, G.; Kini, R.M. Regulation of expression of
venom toxins: Silencing of prothrombin activator trocarin d by ag-rich motifs. FASEB J. 2016, 30, 2411–2425.
[CrossRef] [PubMed]
72. Feldman, C.R.; Durso, A.M.; Hanifin, C.T.; Pfrender, M.E.; Ducey, P.K.; Stokes, A.N.; Barnett, K.E.;
Brodie, E.D., 3rd; Brodie, E.D., Jr. Is there more than one way to skin a newt? Convergent toxin resistance in
snakes is not due to a common genetic mechanism. Heredity (Edinb) 2016, 116, 84–91. [CrossRef] [PubMed]
73. McGlothlin, J.W.; Kobiela, M.E.; Feldman, C.R.; Castoe, T.A.; Geffeney, S.L.; Hanifin, C.T.; Toledo, G.;
Vonk, F.J.; Richardson, M.K.; Brodie, E.D.; et al. Historical contingency in a multigene family facilitates
adaptive evolution of toxin resistance. Curr. Biol. 2016, 26, 1616–1621. [CrossRef] [PubMed]
74. Soong, T.W.; Venkatesh, B. Adaptive evolution of tetrodotoxin resistance in animals. Trends Genet. 2006, 22,
621–626. [CrossRef] [PubMed]
75. Padeken, J.; Zeller, P.; Gasser, S.M. Repeat DNA in genome organization and stability. Curr. Opin. Genet. Dev.
2015, 31, 12–19. [CrossRef] [PubMed]
76. Marcinkiewicz, C. Functional characteristic of snake venom disintegrins: Potential therapeutic implication.
Curr. Pharm. Des. 2005, 11, 815–827. [CrossRef] [PubMed]
77. Laing, G.D.; Moura-da-Silva, A.M. Jararhagin and its multiple effects on hemostasis. Toxicon 2005, 45,
987–996. [CrossRef] [PubMed]
78. McCleary, R.J.; Kini, R.M. Non-enzymatic proteins from snake venoms: A gold mine of pharmacological
tools and drug leads. Toxicon 2013, 62, 56–74. [CrossRef] [PubMed]
79. Kini, R.M.; Doley, R. Structure, function and evolution of three-finger toxins: Mini proteins with multiple
targets. Toxicon 2010, 56, 855–867. [CrossRef] [PubMed]
80. Wagstaff, S.C.; Laing, G.D.; Theakston, R.D.; Papaspyridis, C.; Harrison, R.A. Bioinformatics and
multiepitope DNA immunization to design rational snake antivenom. PLoS Med. 2006, 3. [CrossRef]
[PubMed]
81. Bird, A. Perceptions of epigenetics. Nature 2007, 447, 396–398. [CrossRef] [PubMed]
82. Karlsson, E.; Larkeryd, A.; Sjodin, A.; Forsman, M.; Stenberg, P. Scaffolding of a bacterial genome using
minion nanopore sequencing. Sci. Rep. 2015, 5. [CrossRef] [PubMed]
83. Lu, H.; Giordano, F.; Ning, Z. Oxford nanopore minion sequencing and genome assembly.
Genom. Proteom. Bioinform. 2016, 31, 265–279. [CrossRef] [PubMed]
84. Xiao, W.; Wu, L.; Yavas, G.; Simonyan, V.; Ning, B.; Hong, H. Challenges, solutions, and quality metrics of
personal genome assembly in advancing precision medicine. Pharmaceutics 2016, 8. [CrossRef] [PubMed]
85. Levy-Sakin, M.; Ebenstein, Y. Beyond sequencing: Optical mapping of DNA in the age of nanotechnology
and nanoscopy. Curr. Opin. Biotechnol. 2013, 24, 690–698. [CrossRef] [PubMed]
86. Saliba, A.E.; Westermann, A.J.; Gorski, S.A.; Vogel, J. Single-cell RNA-seq: Advances and future challenges.
Nucleic Acids Res. 2014, 42, 8845–8860. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
